Epstein Secrets

ompromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory gu

h Battle With China. In his column in the Washington Post (7/21, 14.2M), David Ignatius writes, "New US sanctions against the Chinese telecom giant Huawei are beginning to bite hard, with a British assessment predicting that the firm may begin running out of complex, US-designed semiconductors and othe

s-may- ready-early-2021/5478232002/> (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Modema and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory guid

020/07/21/76129704-cb79-11ea-91f1-28aca4d833a0_story.html> (7/21, 14.2M), David Ignatius writes, "New US sanctions against the Chinese telecom giant Huawei are beginning to bite hard, with a British assessment predicting that the firm may begin running out of complex, US- designed semiconductors and oth

. The New York Post <https://nypost.corn/2020/07/30/johnson-johnson-starts-human-vaccine-trials-after-monkey- study/> (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmaker

's Uphill Battle To Create A Culture For Cybersecurity. • Volunteer Experts Seek To Assist US Election Cybersecurity. • Portugal Telecoms Won't Use Huawei For Core 5G Networks Despite Lack Of Official Ban. • Hackers Post Fake Stories On Real News Sites. • Gallagher Says Pentagon Needs Access To Defens

uccia, Subscription Publication, 8.41M), Politico (1/26, Cancryn, Roubein, 6.73M), and The Hill (1/26, Sullivan, Samuels, 5.69M) also have reports. Johnson & Johnson Expects To Report Vaccine Data Next Week. Reuters (1/26, Mishra, O'Donnell) reports that on Tuesday, Johnson & Johnson "said it expected to report

list. The Washington Examiner (1/26, Dunleavy, 888K) reports President Biden's nominee to "lead the Commerce Department would not commit to keeping Huawei on the US entities blacklist after the Trump Administration deemed the Chinese telecom company a national security threat and sought to limit its s

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

's Uphill Battle To Create A Culture For Cybersecurity. • Volunteer Experts Seek To Assist US Election Cybersecurity. • Portugal Telecoms Won't Use Huawei For Core 5G Networks Despite Lack Of Official Ban. • Hackers Post Fake Stories On Real News Sites. • Gallagher Says Pentagon Needs Access To Defens

ompromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory gu

h Battle With China. In his column in the Washington Post (7/21, 14.2M), David Ignatius writes, "New US sanctions against the Chinese telecom giant Huawei are beginning to bite hard, with a British assessment predicting that the firm may begin running out of complex, US-designed semiconductors and oth

ine Use. The Washington Post (4/22, Al, McGinley, Sun, 10.52M) reports, "Federal health authorities are leaning toward recommending that use of the Johnson & Johnson coronavirus vaccine resume, possibly as soon as this weekend - a move that would include a new warning about a rare complication involving blood cl

China by name, his remarks are largely aimed at Beijing's growing strength in high technology, revealed recently by the row over the deployment of Huawei kit in Britain's 5G mobile phone networks." There are also "growing concerns about Russian state-sponsored hacking." This is showing "signs of incr

ompromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory gu

h Battle With China. In his column in the Washington Post (7/21, 14.2M), David Ignatius writes, "New US sanctions against the Chinese telecom giant Huawei are beginning to bite hard, with a British assessment predicting that the firm may begin running out of complex, US-designed semiconductors and oth

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

's Uphill Battle To Create A Culture For Cybersecurity. • Volunteer Experts Seek To Assist US Election Cybersecurity. • Portugal Telecoms Won't Use Huawei For Core 5G Networks Despite Lack Of Official Ban. • Hackers Post Fake Stories On Real News Sites. • Gallagher Says Pentagon Needs Access To Defens